
Analysis Identifies Potential Response, Resistance Biomarkers to Mogamulizumab in R/R Mycosis Fungoides/Sézary Syndrome
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxQQWNvektYai1kN2tucVJ1NklVT1d3TVc3UjZrUDFmcERVWFdvVW4ycHhMcVluN3dVSms2Z2tEMXVDUm5JNHpPaHZCV3BpeDdoQkczWl9QdEJBeFNuaXNDdkpHdEI2c0lfbnEzQXFtRUJzdE52M09mNlN4c2QwUGF3UXd6aWJab3BmdEFMcWJGQ0I4RFJYVFp3OW9QLS1qZDVLckJoSTlXRGlrSGEyM0w0SVlLWkV6ekRYUUYyS2h2bVZJSnlpY1Z5UTV0QlBpMUpUZVEwV203ZEwxVkxISnM0eQ?oc=5" target="_blank">Analysis Identifies Potential Response, Resistance Biomarkers to Mogamulizumab in R/R Mycosis Fungoides/Sézary Syndrome</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>
